SCHEMBL20820918

SCHEMBL20820918

O=C1CCC(=O)N1C(=O)c1ccccc1-c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.58
▸ RECQL P46063 1/20 0.58
▸ BCAT2 O15382 1/20 0.50
▸ LMNA P02545 3/20 0.48
▸ SLC6A7 Q99884 1/20 0.48
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ CHRNB2 P17787 1/20 0.45
▸ CHRNB4 P30926 1/20 0.45
▸ CHRNA3 P32297 1/20 0.45
▸ CHRNA4 P43681 1/20 0.45
▸ SCN1A P35498 2/20 0.44
▸ SCN2A Q99250 2/20 0.44
▸ SCN3A Q9NY46 2/20 0.44
▸ CDK4 P11802 1/20 0.44
▸ CCND1 P24385 1/20 0.44
▸ HNF4A P41235 1/20 0.43
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1270480 0.80 ALDH1A1 (0.54) TSHRMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL11577645 0.75 RXFP1 (0.51) LMNAMEN1KMT2ASMN1; SMN2ALDH1A1
SCHEMBL669626 0.74 KMT2A (0.54) KMT2AALDH1A1
SCHEMBL11575158 0.72 BCHE (0.56) LMNAMEN1KMT2AALDH1A1
SCHEMBL30498780 0.72 TSHR (0.97) TSHRRECQLLMNASLC6A7MEN1
SCHEMBL22692601 0.72 TSHR (0.97) TSHRRECQLLMNASLC6A7MEN1
Benzene SCHEMBL28480917 0.71 HNF4A (0.69) TSHRRECQLBCAT2MEN1KMT2A
Benzene SCHEMBL1403559 0.71 HNF4A (0.69) TSHRRECQLBCAT2MEN1KMT2A
SCHEMBL133057 0.71 HNF4A (0.69) TSHRRECQLBCAT2MEN1KMT2A
SCHEMBL3806467 0.71 BCAT2 (0.68) TSHRRECQLBCAT2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10232360-B1 Use of organic dopants to enhance acetylene hydrogenation catalysts CHEVRON PHILLIPS CHEMICAL COMPANY, LP (US) 2019-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10232360-B1 Use of organic dopants to enhance acetylene hydrogenation catalysts AHR, AOC2, HRH3 TSHR 2598/4885RECQL 4724/4885BCAT2 671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback